Pathway-based Drug Repurposing
Pathway-Based Drug Repurposing is a mechanism-based drug repurposing approach that identifies new therapeutic indications for existing drugs by analyzing their effects on disease-associated biological pathways rather than individual molecular targets.
32
Publications
2.8K
Citations
219
Authors
109
Institutions
Publications per year
2017–2026
27
Parents
32
Drug repurposing from an academic perspective
Tudor I. Oprea, Julie E. Bauman, Cristian Bologa et al. · Drug Discovery Today Therapeutic Strategies · 2011 · 369 citations
1–5 of 32
219
2
h-index
2
h-index
2
h-index
2
h-index
2
h-index
1–5 of 219
109
Illumina (United States)
San Diego, United States
2 h-index
4 publications
2.2K citations
Tongji University
Shanghai, China
2 h-index
2 publications
31 citations
Farr Institute
London, United Kingdom
2 h-index
13 publications
6.7K citations

European Bioinformatics Institute
Cambridge, United Kingdom
2 h-index
8 publications
4.4K citations
University of Cambridge
Cambridge, United Kingdom
2 h-index
14 publications
837 citations
University College London
London, United Kingdom
2 h-index
14 publications
7.7K citations
East China University of Science and Technology
Shanghai, China
2 h-index
9 publications
165 citations

National and Kapodistrian University of Athens
Athens, Greece
2 h-index
2 publications
56 citations
1–8 of 109
3 publications · 100 citations
3
h-index
2 publications · 404 citations
2
h-index
1 publications · 18 citations
1
h-index
Repository · 1 publications · 71 citations
1
h-index
1 publications · 14 citations
1
h-index
1–5